{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:17:20Z","timestamp":1790763440565,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000289","name":"cancer research uk","doi-asserted-by":"publisher","award":["A15151"],"award-info":[{"award-number":["A15151"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12885-016-2573-x","type":"journal-article","created":{"date-parts":[[2016,7,25]],"date-time":"2016-07-25T10:17:24Z","timestamp":1469441844000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A cohort analysis of men with a family history of BRCA1\/2 and Lynch mutations for prostate cancer"],"prefix":"10.1186","volume":"16","author":[{"given":"Lynne","family":"Kerr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Rewhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Longmuir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sioban","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Andrew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hing Y.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,25]]},"reference":[{"key":"2573_CR1","unstructured":"Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, et al. SEER Cancer Statistics Review, 1975\u20132012, National Cancer Institute. Bethesda, MD, http:\/\/seer.cancer.gov\/csr\/1975_2012\/, based on November 2014 SEER data submission, posted to the SEER web site, April 2015"},{"key":"2573_CR2","first-page":"1033","volume":"22","author":"Y Chen","year":"2003","unstructured":"Chen Y, Wang J, Fraig MM, Henderson K, Bissada NK, Watson DK, et al. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer. Int J Oncol. 2003;22:1033\u201343.","journal-title":"Int J Oncol"},{"key":"2573_CR3","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.eururo.2008.08.008","volume":"54","author":"M Roupret","year":"2008","unstructured":"Roupret M, Yates DR, Comperat E, Cussenot O. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch Syndrome) tumour spectrum. Eur Urol. 2008;54:1226\u201336.","journal-title":"Eur Urol"},{"key":"2573_CR4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1158\/1055-9965.EPI-13-1165","volume":"23","author":"S Ryan","year":"2014","unstructured":"Ryan S, Jenkins MA, Win AK. Risk of prostate cancer in Lynch syndrome: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2014;23:437\u201349.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2573_CR5","doi-asserted-by":"publisher","DOI":"10.1200\/EdBook_AM.2013.33.e50","author":"E Castro","year":"2013","unstructured":"Castro E, Goh CL, Eeles RA. Prostate cancer screening in BRCA and Lynch syndrome mutation carriers. Am Soc Clin Oncol Educ Book. 2013. doi: 10.1200\/EdBook_AM.2013.33.e50 .","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2573_CR6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1155\/2004\/136734","volume":"20","author":"JW Bacher","year":"2004","unstructured":"Bacher JW, Flanagan LA, Smalley RL, Nassif NA, Burgart LJ, Halberg RB, et al. Development of a fluorescent multiplex assay for detection of MSI-High tumors. Dis Markers. 2004;20:237\u201350.","journal-title":"Dis Markers"},{"key":"2573_CR7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.eururo.2014.01.003","volume":"66","author":"EK Bancroft","year":"2014","unstructured":"Bancroft EK, Page EC, Castro E, Lilja H, Vickers A, Sjoberg D, et al. Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study. Eur Urol. 2014;66:489\u201399.","journal-title":"Eur Urol"},{"key":"2573_CR8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, et al. Signatures of mutational processes in human cancer. Nature. 2013;500:415\u201321.","journal-title":"Nature"},{"key":"2573_CR9","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1200\/JCO.2012.44.1238","volume":"31","author":"VM Raymond","year":"2013","unstructured":"Raymond VM, Mukherjee B, Wang F, Huang SC, Stoffel EM, Kastrinos F, et al. Elevated risk of prostate cancer among men with Lynch syndrome. J Clin Oncol. 2013;31:1713\u20138.","journal-title":"J Clin Oncol"},{"key":"2573_CR10","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1200\/JCO.2011.39.5590","volume":"30","author":"AK Win","year":"2012","unstructured":"Win AK, Young JP, Lindor NM, Tucker KM, Ahnen DJ, Young GP, et al. Colorectal and other cancer risks for carriers and non carriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol. 2012;30:958\u201364.","journal-title":"J Clin Oncol"},{"key":"2573_CR11","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1464-410x.2000.00457.x","volume":"85","author":"O Bratt","year":"2000","unstructured":"Bratt O. Hereditary prostate cancer. BJU Int. 2000;85:588\u201398.","journal-title":"BJU Int"},{"key":"2573_CR12","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1158\/1055-9965.EPI-09-0058","volume":"18","author":"EM Grindedal","year":"2009","unstructured":"Grindedal EM, Moller P, Eeles R, Stormorken AT, Bowitz-Lothe IM, Landr\u00f8 SM, et al. Germ-line mutations in mismatch repair genes associated with prostate cancer. Cancer Epidemiol Biomarkers Prev. 2009;18:2460\u20137.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2573_CR13","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1038\/sj.onc.1204625","volume":"20","author":"Q Wang","year":"2001","unstructured":"Wang Q, Zhang H, Guerrette S, Chen J, Mazurek A, Wilson T, et al. Adenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1. Oncogene. 2001;20:4640\u20139.","journal-title":"Oncogene"},{"key":"2573_CR14","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.15252\/embj.201387530","volume":"33","author":"M Peng","year":"2014","unstructured":"Peng M, Xie J, Ucher A, Stavnezer J, Cantor SB. Crosstalk between BRCA-Fanconi anemia and mismatch repair pathways prevents MSH2-dependent aberrant DNA damage responses. EMBO J. 2014;33:1698\u2013712.","journal-title":"EMBO J"},{"key":"2573_CR15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.eururo.2014.10.022","volume":"68","author":"E Castro","year":"2015","unstructured":"Castro E, Goh C, Leongamornlert D, Saunders E, Tymrakiewicz M, Dadaev T, et al. Effect of BRCA mutations on metastatic relapse and cause-specific survival after radical treatment for localised prostate cancer. Eur Urol. 2015;68:186\u201393.","journal-title":"Eur Urol"},{"key":"2573_CR16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10689-014-9744-1","volume":"13","author":"C Rosty","year":"2014","unstructured":"Rosty C, Walsh MD, Lindor NM, Thibodeau SN, Mundt E, Gallinger S, et al. High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registry. Familial Cancer. 2014;13:573\u201382.","journal-title":"Familial Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2573-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T15:06:50Z","timestamp":1498316810000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-016-2573-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,25]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2573"],"URL":"https:\/\/doi.org\/10.1186\/s12885-016-2573-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,25]]},"article-number":"529"}}